EE351 Estimated Annual Treatment Cost of Hemophilia A Prophylaxis in the United States: Comparison of Jivi® with the Other Extended Half Life (EHL) Factor VIII Products
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.599
https://www.valueinhealthjournal.com/article/S1098-3015(22)00800-2/fulltext
Title :
EE351 Estimated Annual Treatment Cost of Hemophilia A Prophylaxis in the United States: Comparison of Jivi® with the Other Extended Half Life (EHL) Factor VIII Products
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00800-2&doi=10.1016/j.jval.2022.04.599
First page :
Section Title :
Open access? :
No
Section Order :
10536